World Acceptance (WRLD) Insider Offloads Minor Stake in August 2025

Rhea-AI Filing Summary

World Acceptance Corp. (WRLD) Form 4: Director Charles D. Way reported selling 402 common shares on 06 Aug 2025 at $160 per share (transaction code “S”), a gross value of roughly $64 k. Following the sale, Way directly holds 15,395 WRLD shares. No derivative securities were involved and the filing does not reference a Rule 10b5-1 trading plan. The sale represents about 2.6 % of his direct stake and an immaterial fraction of the company’s shares outstanding, suggesting limited market impact.

Positive

• None.

Negative

• Director disposed of shares; while small, insider selling can be interpreted negatively by some investors.

Insights

Financial Analyst

TL;DR: Small discretionary insider sale; neutral outlook.

The 402-share sale equals ~2.6 % of the director’s ownership and <0.1 % of float, providing negligible supply pressure. Lack of a 10b5-1 plan could hint at opportunistic timing, yet volume and value are modest. I see no meaningful signal regarding WRLD’s fundamentals or governance and classify the event as routine.

Corporate Governance Specialist

TL;DR: Routine Form 4 with minimal governance implications.

No policy breaches or pattern of significant insider selling are evident. Way retains over 15 k shares, maintaining alignment with shareholder interests. The single, small transaction does not alter board independence assessments or trigger additional disclosure requirements.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

WAY CHARLES D

(Last) (First) (Middle)

104 S MAIN ST

SUITE 400

(Street)

GREENVILLE SC 29601

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
WORLD ACCEPTANCE CORP [ WRLD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/06/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
COMMON STOCK, NO PAR VALUE	08/06/2025		S		402	D	$160	15,395	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	/s/Bert De Los Santos Attorney-in-fact	08/07/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many WRLD shares did Director Charles D. Way sell?

He sold 402 common shares.

At what price were the shares sold according to the Form 4?

The reported sale price was $160 per share.

How many WRLD shares does the director still own after the sale?

Way directly owns 15,395 shares following the transaction.

Was the transaction executed under a Rule 10b5-1 trading plan?

The filing does not indicate that the sale was made under a Rule 10b5-1 plan.

Did the Form 4 include any derivative security activity?

No; Table II shows no derivative securities acquired or disposed of.